Consolis

Consolis

Design and manufacturing of high performance concrete products

Cisbio operates mostly in Life Sciences Drug Discovery. It also has a small In-Vitro Diagnostics business unit. It serves clients through both a direct sales organization and distributors. It has 3 overseas subsidiaries (USA, China, Japan). Life Sciences activities serve big pharmas as well as biotechs and university research institutes. They focus on developing reagents at early phases of the biopharma R&D value chain, when biotechs/pharmas perform series of key tests to bring therapeutic candidates to clinical trials. The group IVD activities manufacture reagents to perform tests on biological samples (e.g.: blood, urine, tissues) to diagnose diseases in medical laboratories.

Date of capital investment

October 2005

Type of deal

2nd LMBO

Turnover

1196m€

Number of employees

9758

Date of transfer

March 2007

Type of transfer

Secondary LBO to LBO France